April 18th, 2013
Advice for Physicians: How to Behave Online
Larry Husten, PHD
Although the internet represents “a new frontier in medicine” for physicians and patients, it also presents numerous and novel challenges to professionalism, according to a position paper from the American College of Physicians and the Federation of State Medical Boards published in the Annals of Internal Medicine.
The paper offers physicians a new conceptual “framework for analyzing medical ethics and professionalism issues” on the internet and provides recommendations for physicians on the use of email, blogs, social media sites, and more.
Although there are numerous valuable educational resources available, the authors advise physicians to evaluate the quality of online content before giving recommendations to their patients. Physicians who use blogs, Twitter, and other outlets to vent against patients are “disrespectful” and may “undermine trust in the profession.”
The paper also discusses the problem of confidentiality in the digital age and maintaining security on mobile devices.
The authors recommend that physicians maintain clear and distinct professional and social identities online, but professional standards must be maintained in both spheres. Patients should not be “friended” by physicians and should not be included in the personal or social online interactions of physicians. The authors also advise physicians and physicians-in-training that medical humor, though intended for fellow professionals, can easily find a wider audience on the internet.
Categories: General
Tags: American College of Physicians, online behavior, professionalism, social media
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Survodutide Once Weekly for the Treatment of Adults with Obesity August 20, 2026In a phase 3 trial involving adults with obesity but without diabetes, the glucagon receptor–GLP-1 receptor dual agonist survodutide led to significantly greater reductions in body weight than placebo.
- The Broader Dangers of Abandoning SGM Health Research August 20, 2026When research is defunded not for scientific reasons but because it has become politically inconvenient, the ensuing damage is wide ranging, affecting far more than the disfavored topics and populations.
- A New Approach to Lowering LDL Cholesterol August 13, 2026The pioneering work of Vafai and colleagues, reported in this issue of the Journal,1 paves the way for a new type of low-density lipoprotein (LDL) cholesterol–lowering therapy called VERVE-102: a therapy that appears to lower LDL cholesterol levels enough to reduce the risk of atherosclerotic cardiovascular...
- Last Man Running August 13, 2026As the health of his brother and running buddy rapidly declines and he faces his own health scares, a physician feels compelled — and grateful — to keep moving forward.
- In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia August 13, 2026The authors report reductions in PCSK9 and LDL cholesterol levels and no dose-limiting toxic effects in persons with hypercholesterolemia treated with VERVE-102, a base editor targeting PCSK9.
- Survodutide Once Weekly for the Treatment of Adults with Obesity August 20, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
